PDCD1LG2 and neoplasm: In their follow up study they aimed to further investigate various factors that might predict a response to anti-PD-1 therapy including PD-L1 expression by tumor cells, PD-L1 expression by infiltrating immune cells, PD-L2 expression by tumor cells and other tumor microenvironment factors.